Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (374), 10.1186/s13046-021-02176-2)

Xin Peng, Shaolu Zhang, Wenhui Jiao, Zhenxing Zhong, Yuqi Yang, Francois X. Claret, Moshe Elkabets, Feng Wang, Ran Wang, Yuxu Zhong, Zhe Sheng Chen, Dexin Kong

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

Following publication of the original article [1], author found an error about the information of the last author, Dexin Kong, which was made in the production stage of the publication. The information indicating Dexin Kong as a corresponding author was missing, including the symbol "*" on his name and his email address. Such information has been added. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.

Original languageEnglish
Article number396
JournalJournal of Experimental and Clinical Cancer Research
Volume40
Issue number1
DOIs
StatePublished - 1 Dec 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (374), 10.1186/s13046-021-02176-2)'. Together they form a unique fingerprint.

Cite this